TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
29 hedge funds and large institutions have $11.5M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 8 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 33 → 29 (-4)
22% less capital invested
Capital invested by funds: $14.7M → $11.5M (-$3.24M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$257K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$75K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.3K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$30.3K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$211K |
| 2 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$164K |
| 3 |
Millennium Management
New York
|
-$138K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$52K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$49.8K |
TLOG Hedge Fund Activity: Q3 2015 in Review
29 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2015, worth a combined $11.5M — down 22% from $14.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TLOG and 4 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Bank of New York Mellon, adding an estimated $257K. The largest seller was Lazard Asset Management, exiting entirely with an estimated $211K sold.
- 29 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2015, down from 33 in Q2 2015.
- Funds reported $11.5M of TetraLogic Pharmaceuticals Corporation stock for Q3 2015, down 22% quarter-over-quarter.
- 4 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2015 and 8 closed out, a net change of -4 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2015 was Bank of New York Mellon, an estimated $257K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2015 was Lazard Asset Management, an estimated $211K sold.
Based on aggregated 13F filings for Q3 2015.